Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Neoplasma ; 54(2): 173-9, 2007.
Article in English | MEDLINE | ID: mdl-17319793

ABSTRACT

Excessive bone formation occurring in such conditions as paravertebral ligamentous ossification, hallux osteophytes or some neoplastic tumors, presents a significant problem, both epidemiological and clinical. Since pathogenesis of this disorder is still unclear, we studied its mechanism in experimental model utilizing inducible orthotopic osteogenesis. Periosteal bone apposition stimulated by Moloney sarcoma is characterized by unusually high volume of new bone tissue appearing subperiosteally in the bone adjacent to the tumor. Genes engaged in this growth have not been characterized so far. Here we show the results of mRNA Representation Difference Analysis in Moloney sarcoma, which reveal high expression of four genes coding extracellular matrix proteins: osteopontin, fibronectin, stromelysin-1 and tenascin. These findings suggest that the uncommon dynamics of the Moloney sarcoma-induced osteogenesis depends on high expression of these extracellular matrix proteins.


Subject(s)
Fibronectins/metabolism , Matrix Metalloproteinase 3/metabolism , Moloney murine sarcoma virus/physiology , Osteogenesis/physiology , Osteopontin/metabolism , Periosteum/virology , Sarcoma, Experimental/etiology , Tenascin/metabolism , Animals , Blotting, Northern , Mice , Mice, Inbred BALB C
2.
J Immunol ; 166(10): 5878-81, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11342601

ABSTRACT

The ability of various infections to suppress neoplastic growth has been well documented. This phenomenon has been traditionally attributed to infection-induced concomitant, cell-mediated antitumor immunity. We found that infection with Toxoplasma gondii effectively blocked neoplastic growth of a nonimmunogenic B16.F10 melanoma. Moreover, this effect was independent of cytotoxic T or NK cells, production of NO by macrophages, or the function of the cytokines IL-12 and TNF-alpha. These findings suggested that antitumor cytotoxicity was not the primary mechanism of resistance. However, infection was accompanied by strong, systemic suppression of angiogenesis, both in a model system and inside the nascent tumor. This suppression resulted in severe hypoxia and avascular necrosis that are incompatible with progressive neoplastic growth. Our results identify the suppression of tumor neovascularization as a novel mechanism critical for infection-induced resistance to tumors.


Subject(s)
Melanoma, Experimental/blood supply , Melanoma, Experimental/immunology , Neovascularization, Pathologic/immunology , Neovascularization, Pathologic/prevention & control , Toxoplasmosis, Animal/immunology , Acute Disease , Animals , Cell Division/immunology , Cytotoxicity, Immunologic , Endothelium, Vascular/immunology , Endothelium, Vascular/parasitology , Endothelium, Vascular/pathology , Immunity, Innate , Melanoma, Experimental/parasitology , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , Mice, SCID , Necrosis , Neoplasm Transplantation , Neovascularization, Pathologic/parasitology , Neovascularization, Pathologic/pathology
3.
Nucleic Acids Res ; 28(11): 2268-75, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10871348

ABSTRACT

The Myc oncoprotein is implicated in transcriptional regulation of a variety of genes pertaining to cell cycle and neoplastic transformation. Examples of both positive and negative regulation have been reported that involve E-box and initiator (Inr) promoter elements, respectively. In both cases, Myc is thought to induce changes in transcription initiation. We have previously shown that overexpression of Myc causes down-regulation of the thrombospondin-1 (tsp-1) gene, an important negative modulator of tumor angiogenesis. In this study, we demonstrate that Myc in combination with Max can bind, albeit with low affinity, to an E-box-like element in the tsp-1 promoter. However, the 2.7 kb DNA segment containing both this non-canonical E-box and an Inr-like sequence does not constitute a Myc-responsive element in a transient expression system. Furthermore, Myc does not significantly affect the rate of initiation or elongation of the tsp-1 mRNA. Thus, in this instance Myc does not act as a canonical transcription factor. Instead, as demonstrated by blocking de novo RNA synthesis, down-regulation of the tsp-1 gene by Myc occurs through increased mRNA turnover. To our knowledge, this is the first example of gene regulation by Myc that involves mRNA destabilization.


Subject(s)
Proto-Oncogene Proteins c-myc/metabolism , RNA, Messenger/metabolism , Thrombospondin 1/genetics , Transcription Factors , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Basic-Leucine Zipper Transcription Factors , Cells, Cultured , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Gene Expression Regulation , Genes, Reporter , Promoter Regions, Genetic , Rats , Regulatory Sequences, Nucleic Acid , Thrombospondin 1/metabolism , Transfection
4.
J Biol Chem ; 275(28): 21055-60, 2000 Jul 14.
Article in English | MEDLINE | ID: mdl-10770937

ABSTRACT

B-MYB is a ubiquitously expressed transcription factor involved in the regulation of cell survival, proliferation, and differentiation. In an attempt to isolate B-MYB-regulated genes that may explain the role of B-MYB in cellular processes, representational difference analysis was performed in neuroblastoma cell lines with different levels of B-MYB expression. One of the genes, the mRNA levels of which were enhanced in B-MYB expressing cells, was ApoJ/Clusterin(SGP-2/TRMP-2) (ApoJ/Clusterin), previously implicated in regulation of apoptosis and tumor progression. Here we show that the human ApoJ/Clusterin gene contains a Myb binding site in its 5' flanking region, which interacts with bacterially synthesized B-MYB protein and mediates B-MYB-dependent transactivation of the ApoJ/Clusterin promoter in transient transfection assays. Endogenous ApoJ/Clusterin expression is induced in mammalian cell lines following transient transfection of a B-MYB cDNA. Blockage of secreted clusterin by a monoclonal antibody results in increased apoptosis of neuroblastoma cells exposed to the chemotherapeutic drug doxorubicin. Thus, activation of ApoJ/Clusterin by B-MYB may be an important step in the regulation of apoptosis in normal and diseased cells.


Subject(s)
Cell Cycle Proteins , DNA-Binding Proteins/metabolism , Glycoproteins/genetics , Molecular Chaperones , Promoter Regions, Genetic , Trans-Activators/metabolism , Transcription, Genetic , Transcriptional Activation , Animals , Base Sequence , COS Cells , Clusterin , Glycoproteins/biosynthesis , Humans , Molecular Sequence Data , Neoplasm Proteins/genetics , Neuroblastoma , Oncogene Proteins/metabolism , RNA, Messenger/genetics , Rats , Recombinant Proteins/biosynthesis , Sequence Alignment , Sequence Homology, Nucleic Acid , Transfection , Tumor Cells, Cultured
5.
Cancer Res ; 59(23): 5882-6, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-10606228

ABSTRACT

Loss of function of mismatch repair (MMR) genes underlies hereditary nonpolyposis colorectal cancer (HNPCC). However, the inability to maintain primary colon epithelial cells in culture has limited the analysis of the contribution of MMR gene defects to colorectal tumorigenesis. We have now established primary cultures of epithelial cells from the colon crypts of Msh2-/- p53-/- double-knockout mice. These cells undergo spontaneous transformation (soft agar colonies and s.c. tumor formation), with a progressively shorter latency as a function of increasing passages in culture. Treatment of early passage cells with the mutagen methylmethane thiosulfonate (MMS) further decreases the transformation latency of Msh2-/- p53-/- cells. Spontaneous transformation of p53-/- colonocytes is only observed using late passage cells, and methylmethane thiosulfonate-treated early passage p53-/- colonocytes do not form tumors when injected into immunodeficient mice. Together, these findings support the pathogenic role of MMR gene inactivation in colorectal tumorigenesis and provide an experimental model for the serial assessment of the molecular phenotype associated with Msh2 deficiency.


Subject(s)
Cell Transformation, Neoplastic , Colon/pathology , Colonic Neoplasms/pathology , DNA-Binding Proteins , Genes, p53 , Intestinal Mucosa/pathology , Proto-Oncogene Proteins/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Base Pair Mismatch , Cell Division , Cells, Cultured , Colon/drug effects , Colonic Neoplasms/genetics , Intestinal Mucosa/drug effects , Intestinal Mucosa/ultrastructure , Male , Methyl Methanesulfonate/toxicity , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Knockout , Mice, SCID , MutS Homolog 2 Protein , Proto-Oncogene Proteins/deficiency , Proto-Oncogene Proteins/genetics , Transplantation, Heterologous , Tumor Suppressor Protein p53/deficiency
6.
J Clin Invest ; 101(8): 1572-80, 1998 Apr 15.
Article in English | MEDLINE | ID: mdl-9541486

ABSTRACT

Distinct genetic abnormalities (loss-of-function mutations of APC and p53 and oncogenic activation of Ki-ras) are associated with specific stages of the sporadic, most common types of colorectal tumors. However, the inability to maintain primary colon epithelial cells in culture has hindered the analysis of the pathogenetic role of these abnormalities in colorectal tumorigenesis. We have now established primary cultures of epithelial cells from the colon crypts of p53-deficient mice; these cells are nontumorigenic as indicated by their failure to form colonies in soft agar and to grow as tumors in immunodeficient SCID mice and in immunocompetent syngeneic hosts. Upon ectopic expression of an activated Ki-ras gene, p53-deficient colon epithelial cells form colonies in soft agar and highly invasive subcutaneous tumors in both immunodeficient and immunocompetent mice. Ectopic expression of wild-type p53, but not of a DNA-binding-deficient mutant, markedly suppressed the colony-forming ability of the Ki-ras-transformed p53-deficient epithelial cells. Together, these findings establish a functional synergism in colorectal tumorigenesis dependent on the effects of an oncogenic Ki-ras in a p53-deficient background. This model of tumorigenic conversion of colon epithelial cells might be useful to identify genetic changes associated with disease progression and to evaluate the therapeutic response to conventional and novel anticancer drugs.


Subject(s)
Colonic Neoplasms/genetics , Genes, p53 , Genes, ras , Animals , Base Sequence , Cell Transformation, Neoplastic/genetics , Colon/metabolism , Colon/pathology , Colonic Neoplasms/etiology , Colonic Neoplasms/pathology , Colorectal Neoplasms/etiology , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , DNA Primers/genetics , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Gene Expression Regulation , Humans , Male , Mice , Mice, Knockout , Mice, SCID , Microscopy, Electron , Retroviridae/genetics , Transfection , Tumor Stem Cell Assay
7.
Blood ; 91(8): 2998-3006, 1998 Apr 15.
Article in English | MEDLINE | ID: mdl-9531612

ABSTRACT

Prompt reconstitution of hematopoiesis after cytoreductive therapy is essential for patient recovery and may have a positive impact on long-term prognosis. We examined the role of the p53 tumor suppressor gene in hematopoietic recovery in vivo after treatment with the cytotoxic drug 5-fluorouracil (5-FU). We used p53 knock-out (p53-/-) and wild-type (p53+/+) mice injected with 5-FU as the experimental model. Analysis of the repopulation ability and clonogenic activity of hematopoietic stem cells (HSCs) and their lineage-committed descendants showed a greater number of HSCs responsible for reconstitution of lethally irradiated recipients in p53-/- bone marrow cells (BMCs) recovering after 5-FU treatment than in the corresponding p53+/+ BMCs. In post-5-FU recovering BMCs, the percentage of HSC-enriched Lin- Sca-1(+) c-Kit+ cells was about threefold higher in p53-/- than in p53+/+ cells. Although the percentage of the most primitive HSCs (Lin- Sca-1(+) c-Kit+ CD34(low/-)) did not depend on p53, the percentage of multipotential HSCs and committed progenitors (Lin- Sca-1(+) c-Kit+ CD34(high/+)) was almost fourfold higher in post-5-FU recovering p53-/- BMCs than in their p53+/+ counterparts. The pool of HSCs from 5-FU-treated p53-/- BMCs was exhausted more slowly than that from the p53+/+ population as shown in vivo using pre-spleen colony-forming unit (CFU-S) assay and in vitro using long-term culture-initiating cells (LTC-ICs) and methylcellulose replating assays. Clonogenic activity of various lineage-specific descendants was significantly higher in post-5-FU regenerating p53-/- BMCs than in p53+/+ BMCs, probably because of their increased sensitivity to growth factors. Despite all these changes and the dramatic difference in sensitivity of p53-/- and p53+/+ BMCs to 5-FU-induced apoptosis, lineage commitment and differentiation of hematopoietic progenitors appeared to be independent of p53 status. These studies suggest that suppression of p53 function facilitates hematopoietic reconstitution after cytoreductive therapy by: (1) delaying the exhaustion of the most primitive HSC pool, (2) stimulating the production of multipotential HSCs, (3) increasing the sensitivity of hematopoietic cells to growth factors, and (4) decreasing the sensitivity to apoptosis.


Subject(s)
Antimetabolites/toxicity , Apoptosis/genetics , Fluorouracil/toxicity , Hematopoiesis/genetics , Tumor Suppressor Protein p53/genetics , Animals , Apoptosis/drug effects , Gene Expression Regulation/drug effects , Genes, Tumor Suppressor/genetics , Hematopoiesis/drug effects , Mice , Mice, Knockout
8.
Arzneimittelforschung ; 45(8): 891-3, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7575755

ABSTRACT

[D-Ala1]peptideT-amide, the linear hexapeptide H-Thr-Hse-Asn-Tyr-Thr-Asp-OH (LPT) and its cyclic analog, cyclo(-Thr-Hse-Asn-Tyr-Thr-Asp-) (CPT), were tested for their effects on the proliferation of cultured normal human keratinocytes (KTs) in comparison with vasoactive intestinal peptide (VIP). [D-Ala1]PT-NH2, LPT and VIP (all 0.1 mumol/l) increased the cell number in KT cultures, whereas CPT was ineffective. The VIP antagonist [N-Ac-Tyr1,D-Phe2]GRF (1-29)-NH2 significantly inhibited the VIP effects on KTs. On the other hand this antagonist did not affect the peptide T (PT) compounds-induced stimulation of KTs, providing indirect evidence that the mitogenic effects of VIP and PT peptides are probably mediated via different receptors.


Subject(s)
Keratinocytes/drug effects , Peptide T/analogs & derivatives , Peptide T/pharmacology , Adenosine/pharmacology , Amino Acid Sequence , Animals , Cell Division/drug effects , Cells, Cultured , Humans , In Vitro Techniques , Insulin/metabolism , Insulin Secretion , Molecular Sequence Data , Rats , Stimulation, Chemical , Vasoactive Intestinal Peptide/antagonists & inhibitors , Vasoactive Intestinal Peptide/pharmacology , Verapamil/pharmacology
9.
J Invest Dermatol ; 103(1): 13-8, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8027574

ABSTRACT

Keratinocytes, a key cellular component both for homeostasis and pathophysiologic processes of the skin, secrete a number of cytokines and are stimulated by several growth factors. Nerve growth factor (NGF) is synthesized in the skin and basal keratinocytes express the low-affinity nerve growth factor receptor (NGF-R). We present evidence that normal human keratinocytes in culture express the low- and the high-affinity NGF-R both at the mRNA level, as determined by reverse-transcription polymerase chain reaction and at the protein level, as shown by cytofluorimetric analysis. NGF significantly stimulates the proliferation of normal human keratinocytes in culture in a dose-dependent manner. This effect can be prevented by the addition of both an anti-NGF neutralizing antibody and a high-affinity NGF-R (trk) specific inhibitor, the natural alkaloid K252a. By contrast, keratinocyte proliferation is not inhibited by an anti-low-affinity NGF-R monoclonal antibody, thus suggesting that NGF effect on human keratinocytes is mediated by the high-affinity NGF-R. Moreover, NGF mRNA is expressed in normal human keratinocytes and NGF is secreted by keratinocytes in increasing amounts during growth, as detected by enzyme-linked immunosorbent assay. These results suggest that NGF could act as a cytokine in human skin and take part in disorders of keratinocyte proliferation.


Subject(s)
Keratinocytes/cytology , Nerve Growth Factors/physiology , Receptors, Nerve Growth Factor/physiology , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Base Sequence , Carbazoles/pharmacology , Cell Division/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression , Humans , Indole Alkaloids , Keratinocytes/chemistry , Keratinocytes/ultrastructure , Molecular Sequence Data , Nerve Growth Factors/analysis , Nerve Growth Factors/pharmacology , Polymerase Chain Reaction , Protein Kinase C/antagonists & inhibitors , RNA, Messenger/analysis , RNA, Messenger/genetics , Receptors, Nerve Growth Factor/analysis , Receptors, Nerve Growth Factor/genetics
10.
J Invest Dermatol ; 101(3): 301-4, 1993 Sep.
Article in English | MEDLINE | ID: mdl-7690377

ABSTRACT

Substance P has been detected in human skin and has been implicated in the pathogenesis of certain inflammatory cutaneous disorders. However, little is known about the number and distribution of substance P binding sites in the skin. Receptor autoradiography was employed to detect and quantitate substance P receptors in normal as well as psoriatic skin. Substance P binding sites were distributed in the epidermis and dermis both in normal and psoriatic skin. In the dermis, the highest densities of SP binding sites were found in the areas corresponding to the dermal papillae and the adnexal structures. Quantitative analysis revealed that saturable binding was obtained both in the epidermis and in the labeled dermal areas. Rosenthal plot values were consistent with a single population of binding sites. No difference in the binding measurements was observed between normal and psoriatic skin. The presence of substance P receptors in the epidermis and in the dermal papillae raises interesting issues on the possible targets of this peptide in human skin both under physiologic and pathologic conditions.


Subject(s)
Psoriasis/pathology , Receptors, Neurotransmitter/analysis , Skin/ultrastructure , Autoradiography , Binding Sites , Humans , Iodine Radioisotopes , Psoriasis/metabolism , Receptors, Neurokinin-1 , Receptors, Neurotransmitter/metabolism , Skin/metabolism , Substance P/metabolism
11.
J Invest Dermatol ; 98(4): 421-7, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1372339

ABSTRACT

An involvement of neurogenic components in the pathogenesis of psoriatic lesions has been suggested and neuropeptides are thought to play a modulatory role in cutaneous inflammation. In this study, we evaluated the immunoreactivity of the neuropeptides vasoactive intestinal polypeptide (VIP) and substance P (SP) in the skin of patients with chronic plaque psoriasis, by immunohistochemistry and radioimmunoassay. No differences were observed, by immunohistochemistry, in the expression and localization of VIP and SP between psoriatic and normal skin. Using the radioimmunologic technique on whole skin homogenates, VIP levels were significantly increased in psoriatic lesions as compared to normal skin. By contrast, SP levels were significantly lower in lesional and non-lesional psoriatic skin than in normal skin. In addition, we examined the effect of VIP and SP on the proliferation of cultured normal human keratinocytes. VIP (1-28) (1 nM-1 microM) as well as VIP fragments (10-28) (1 nM-1 microM) and (22-28) (1 nM-1 microM) stimulated the proliferation of keratinocytes in a dose-dependent manner, whereas the VIP fragment (1-12) (1 nM-1 microM) was ineffective. The VIP antagonist (N-Ac-Tyr1, D-Phe2)-GRF (1-29)-NH2 (0.1 microM) significantly inhibited the VIP effect on keratinocytes. On the other hand, SP (0.1 microM) not only failed to stimulate keratinocyte growth, but also blocked the VIP-induced stimulation of these cells. The imbalance of cutaneous VIP and SP and their disparate effects on the proliferation of normal human keratinocytes in culture would suggest that these peptides are involved in the pathogenesis of psoriasis and may exert different modulatory activities in the mechanisms underlying the psoriatic lesion.


Subject(s)
Keratinocytes/cytology , Psoriasis/metabolism , Substance P/analysis , Vasoactive Intestinal Peptide/analysis , Cell Division/drug effects , Cells, Cultured , Humans , Immunohistochemistry , Keratinocytes/chemistry , Psoriasis/pathology , Radioimmunoassay , Substance P/pharmacology , Vasoactive Intestinal Peptide/pharmacology
12.
Acta Derm Venereol ; 72(2): 102-5, 1992.
Article in English | MEDLINE | ID: mdl-1350391

ABSTRACT

Most chronic renal failure patients suffer from generalized pruritus. An involvement of cutaneous nerve terminals in the pathogenesis of uremic pruritus has been suggested. Skin specimens from 24 uremic patients and 10 healthy subjects were processed with an indirect immunofluorescence method to investigate the presence and distribution of a number of neuronal markers and neuropeptides. No difference was found between the two groups in the distribution pattern of the positive nerve fibres. However, a reduction in the total number of skin nerve terminals in the uremic patients was detected. No correlation could be found between the immunohistochemical findings and the clinical features. Our results suggest that the skin innervation is altered in most chronic renal failure patients, possibly as a consequence of neuropathy.


Subject(s)
Kidney Failure, Chronic/pathology , Skin/innervation , Adult , Aged , Aged, 80 and over , Female , Humans , Immunohistochemistry , Kidney Failure, Chronic/complications , Male , Middle Aged , Nerve Fibers/chemistry , Nerve Fibers/pathology , Neuropeptides/analysis , Phosphopyruvate Hydratase/analysis , Pruritus/etiology , Pruritus/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...